At the 2014 Cooperative Meeting of the Consortium of Multiple Sclerosis Centers and the Americas Committee for Treatment and Research in Multiple Sclerosis on May 28-31 in Dallas, Acorda Therapeutics will be demonstrating its award-winning MS self™ mobile app designed for patients with multiple sclerosis.
technology
Recommended Posts
- One silent MRI lesion may be enough to consider stronger MS treatment
- It may only be one life with multiple sclerosis, but it’s mine
- Certain cannabis-based therapies may help relieve spasticity in MS
- Greater disability tied to poorer cognitive function in people with RRMS
- FDA OKs first clinical trial testing novel oral therapy in MS patients